Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1779 · · 11 pages · English
LongBio Pharma (Suzhou) Co., Ltd. on 6ix
Earlier from LongBio Pharma (Suzhou)
- 2026 Interim report
- Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
- Voluntary announcement a phase III clinical trial of LP-003 for the indication of seasonal AR met primary endpoints
Later from LongBio Pharma (Suzhou)
- Proposed amendments to the articles of association
- Proposed amendments to the articles of association and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
- Voluntary announcement topline data from the phase ii clinical trial in china of LP-005 for the treatment of pnh
Follow LongBio Pharma (Suzhou) into a list and get an email when it puts out news.
Follow LongBio Pharma (Suzhou)